StonvexLoading…
StonvexStonvexStonvexCore line items from EXR's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $33.70M | $129.48M | $95.48M | $62.95M |
Operating Income | $367.55M | $1.41B | $1.04B | $762.70M |
Net Income | $240.98M | $974.00M | $686.60M | $520.61M |
EPS (Diluted) | $1.14 | $4.59 | $3.23 | $2.45 |
Total Assets | $29.10B | $29.26B | $29.23B | $29.37B |
Total Liabilities | $14.89B | $14.94B | $14.74B | $14.69B |
Cash & Equivalents | $138.99M | $138.92M | $111.93M | $125.05M |
Free Cash Flow OCF − CapEx | $477.50M | $1.29B | $1.17B | $863.53M |
Shares Outstanding | 211.20M | 211.16M | 212.25M | 212.25M |